A new FICCI-DUA Consulting report projects India's medical device market to grow from $14 billion to $250 billion by 2047. Investors are tracking how government initiatives like the PLI scheme and a focus on high-quality maintenance services will drive this long-term expansion. The shift toward regulated, professional maintenance systems remains a critical area for sector health.
India’s medical device industry is targeting a massive long-term expansion, with a new report by the Federation of Indian Chambers of Commerce & Industry (FICCI) and DUA Consulting projecting the market size to reach $250 billion by 2047. This forecast marks a significant growth path from the current valuation of approximately $14 billion. For investors, this trajectory highlights a sector that is attempting to transition from an import-dependent market to a major global manufacturing hub.
Growth Drivers and Government Support
The report identifies rising healthcare demand and the increasing adoption of advanced medical technology as the primary engines for this growth. Government initiatives, particularly the Production Linked Incentive (PLI) scheme, are playing a key role in incentivizing domestic manufacturing. These policies are designed to reduce the country’s heavy reliance on imported medical equipment and improve the global competitiveness of Indian firms. Investors typically monitor these policy developments, as they often determine which companies can scale production and improve profit margins through local manufacturing.
The Importance of Equipment Maintenance
Beyond manufacturing capacity, the report highlights a critical area often overlooked by the market: the lifecycle management and maintenance of medical equipment. The study notes that the long-term value of medical technology depends heavily on reliable servicing. Currently, an estimated 30-40% of maintenance services in India are provided by unregulated entities. This situation poses operational risks, including equipment downtime, safety issues, and cases of misdiagnosis due to faulty calibration or the use of non-certified parts.
To address these risks, the report proposes a risk-tiered maintenance framework that aligns with the Central Drugs Standard Control Organisation (CDSCO) device classification. For the industry, this suggests that companies capable of offering a strong, certified service and maintenance network may gain a competitive advantage. Reliable service is not just about safety; it is essential for the long-term operational effectiveness of hospital infrastructure, which in turn drives recurring revenue for medical device companies.
Sector Challenges and Monitorables
While the growth outlook is positive, the industry continues to face structural hurdles. Despite the push for domestic manufacturing, the sector remains heavily dependent on imports for critical components and technology. Moving toward a fully self-reliant model requires sustained capital investment and the development of local technical expertise. Additionally, the shift toward a more regulated environment for equipment maintenance will require companies to invest in certified engineering talent and digital infrastructure, such as predictive maintenance systems. Investors may track how major players in the sector adapt to these regulatory recommendations, as success will likely depend on the company's ability to balance expansion with compliance and service quality.